Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 342 results for "lupin"

321 images for lupin

One News Page United Kingdom, 2 days ago
Business Today India, 4 days ago
Pharmaceutical Technology, 2 days ago
NDTV Profit, 4 days ago
NDTV Profit, 4 days ago
Livemint.com, 4 days ago
Sify, 6 days ago
NDTV Profit, 6 days ago
Drug Discovery and Development, 1 day ago
Knox Village Soup, 6 hours ago
Nikkei Asian Review

Lupin launches antibiotic drug Zaxine in Canada

The drug was launched under a strategic licensing agreement with the North Carolina based gastrointestinal (GI) specialty company Salix Pharmaceuticals BS B2B Bureau | Mumbai April 20, 2015 Last Updated at 16:19 IST Lupin Pharma Canada Limited, the Canadian ...
 Business Standard6 days ago Indian drugmaker to sell hepatic encephalopathy drug  Nikkei Asian Review6 days ago Lupin gains 2% on launch of antibiotic drug in Canada  Money Control6 days ago Lupin launches asthma drug delivery device in US  Business Standard2 months ago
NDTV Profit

Lupin Falls 8% on Muted Growth Outlook

Shares of pharma company, Lupin fell over 6 per cent to hit intraday low of Rs 1,785 on Friday. The fall came on top of yesterday's 2.6 per cent decline. Morgan Stanley after a meet with Lupin's top management wrote in a report that it expects its ...
 NDTV Profit1 week ago Pharma shares extend fall; CNX Pharma index down 3%  Business Standard India1 week ago Strides, Torrent Pharma, Glenmark, Lupin gain on USFDA nod  Money Control1 week ago Sun Pharma, Lupin, Cipla, Cadila plunge on BoAML downgrade  Money Control2 weeks ago
[x]  
India Infoline

Lupin slips over 7% in three sessions

at 10:07 IST on BSE, extending recent losses triggered by the US health regulator allowing Aurobindo Pharma to sell a generic antibiotic drug Cefixime. Meanwhile, the BSE Sensex was down 71.54 points, or 0.25%, to 28,594.50. On BSE, so ...
 Capital Market1 week ago Lupin falls nearly 8% in three sessions on Suprax generic concerns  Economic Times1 week ago Lupin falls over 4% in two sessions on Suprax generic concerns  Economic Times1 week ago Cefixime effect! Lupin shares slips over 4% in last two sessions  India Infoline1 week ago
Business Standard

MFs offload Lupin, TCS and Motilal Oswal shares

Mutual fund houses offloaded shares of pharmaceutical major Lupin Ltd, information technology (IT) giant Tata Consultancy Services (TCS) and Motilal Oswal Financial Services over the last two months. While fund managers reduced their cash holdings ...
 Smart Investor4 days ago
Business Standard

Lupin's loss is Aurobindo's gain

It is not common amongst Indian pharma peers that a generic approval of a drug has proved to be a boon for one and bane for the other. But, something similar is the case with Lupin's anti-bacterial brand Suprax. As Aurobindo received the approval to ...
 Business Standard India1 week ago Aurobindo gains on Cefixime approval, Lupin loses  Hindu Business Line1 week ago Lupin launches generic hypertension drug in US  Business Standard3 weeks ago Lupin advances on launching generic Exforge in US  India Infoline3 weeks ago
[x]  

Here are top 10 stocks to focus on April 20

Lupin, Bharat Forge, Reliance Industries, LIC Housing Finance, Delta Corp, Titagarh Wagons, Clariant Chemicals, Glenmark Pharma, Bhushan Steel
 MSN News US6 days ago Here are top 10 stocks to keep an eye on February 19  Money Control2 months ago

Lupin heads toward Rs 1,700 level: Tushar Mahajan, Nomura

In a chat with ET Now, Tushar Mahajan, Nomura, HD-Derivatives - Listed F&O, shares his views on pharma stocks. ET Now: Pharmaceutical is now becoming a tricky pocket. How do you pick pharma stocks? Tushar Mahajan: Purely going by the trading ...
 Economic Times5 days ago

Looking at low cost R&D manufacturing in India: Ramesh Swaminathan, Lupin

'If you look at the Indian pharmaceutical industry today, our paradigm today is low-cost manufacturing in India, low-cost R&D and we have been focussing exclusively on generics.' In an interview with ET Now, Ramesh Swaminathan, President, Finance & Planning, ...
 Economic Times6 days ago

'Lupin expects 25-30 product approvals in FY16'

, according to brokerage Barclays Equity Research. "Approvals in the US continue to be a work-in-progress although Lupin management believes that the number of approvals should improve sequentially going ahead. "Management highlighted that the company is ...
 Business Standard1 week ago Big week for bullion  INooz6 days ago Lupin expects 25-30 product approvals in FY 2016  Indian-Commodity6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lupin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less